qqquant

Protagonist Therapeutics, Inc (PTGX)

Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 5, 2026

Profit #611 of 1484 companies

	Jun 26	Mar 26	Dec 25	Sep 25
ROE/ROA	60.1%	12.3%	39.1%	81.4%

Growth #50 of 1484 companies

	Jun 26	Mar 26	Dec 25	Sep 25
Sales andOCF growth	63.8%	-118.6%	-95.5%

Payout #1117 of 1484 companies

	Jun 26	Mar 26	Dec 25	Sep 25
Shareholderdistributions/ net income	0%	0%	0%	0%

Safety #589 of 1484 companies

	Balance	Stability
Equity/assets andOCF stability	94.4%	-41.7%

Price #1239 of 1484 companies

	Earnings	FCF
Earnings andFCF yield	$0.90	$1.41

Menu

Next Earnings Reports

How this site works